Skip to search formSkip to main contentSkip to account menu

Rilimogene Galvacirepvec

Known as: rVaccinia-PSA(L155)-TRICOM Vaccine, rVaccinia-Prostate-Specific Antigen/TRICOM Vaccine, Recombinant Vaccinia-PSA(L155)/TRICOM 
A vaccine formulation consisting of recombinant vaccinia virus encoding prostate specific antigen (PSA) and recombinant vaccinia virus encoding three… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
5083Background: PSA-TRICOM (Prostvac) is a vector-based vaccine designed to generate a robust immune response (IR) against PSA…